Plant Comparison
Tea vs Clove
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Tea and Clove: they share 6 indicated uses (arthritis / joint pain, cancer (anticancer research), infection (general), …); 4 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Tea | Clove | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 1/10 | 2/10 | Comparable evidence |
| Cancer (anticancer research) | 8/10 | 2/10 | Stronger for Tea |
| Infection (general) | 1/10 | 2/10 | Comparable evidence |
| Inflammation (general) | 1/10 | 1/10 | Comparable evidence |
| Skin irritation | 1/10 | 1/10 | Comparable evidence |
| Wounds | 1/10 | 1/10 | Comparable evidence |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
Principal antioxidant polyphenols, most concentrated in minimally oxidised green tea; epigallocatechin gallate (EGCG) is the best studied.
Caffeine gives tea its mild stimulant effect; L-theanine, a unique amino acid, is associated with calm alertness and modulates caffeine's effects.
Oxidative polymerisation products of catechins formed during black tea processing, contributing to black tea's colour and its own antioxidant profile.
Eugenol typically makes up the great majority of clove oil and is responsible for most of its analgesic, antimicrobial and anti-inflammatory activity.
Pharmacological Actions
Traditional & Indicated Uses
inferred from anti-inflammatory action
inferred from antidiabetic action
inferred from anticancer action
inferred from neuroprotective action
inferred from antimicrobial action
inferred from anti-inflammatory action
inferred from anti-inflammatory action
inferred from anti-inflammatory action
inferred from anticancer action
inferred from digestive action
inferred from antimicrobial action
inferred from anti-inflammatory action
inferred from anti-inflammatory action
Safety, Cautions & Contraindications
Generally safe in moderate consumption. High caffeine intake may cause insomnia, anxiety, palpitations, or dependence. Large amounts of green tea extract supplements may be hepatotoxic (rare). May reduce iron absorption if consumed with meals. Avoid very high supplement doses during pregnancy.
Duke (2002) rates tea (Camellia sinensis) as ++ and notes anti-aggregant, antioxidant, anticariogenic, and antibacterial activities at the experimental level (score 1). The catechins (EGCG, ECG) and polyphenols are responsible for the antioxidant and anticancer properties under research investigation. Duke notes that green tea preserves more polyphenols than black tea due to less oxidation. Regular tea consumption is associated with reduced cardiovascular risk. Excess consumption (>10 cups daily) may cause fluoride-related bone changes. Caffeine content is relevant for sleep disturbance, anxiety, and interactions with cardiovascular medications (Duke, 2002).
Strong and concentrated: Clove oil is very potent and should always be diluted before skin or mouth use.Dental use: Undiluted clove oil can burn gums or skin.Blood thinning: Clove may increase bleeding risk in large amounts or with anticoagulants.Pregnancy: Culinary amounts are fine; medicinal doses should be used cautiously.Children: Essential oil should be used with extra caution and diluted well.
Duke (2002) rates cloves as +++ with clinical evidence (score 2) for analgesic activity — specifically, topical application of clove oil (eugenol) for dental pain is clinically validated. The plant also shows strong antimicrobial, antifungal (anti-Candida), antispasmodic, and antiviral activities at the experimental level. Commission E approves topical clove preparations for dental pain. Recommended dose: 1–5% clove oil preparation (topical) or 150 mg clove powder internally. The essential oil is irritating to mucous membranes and should not be applied undiluted to skin or mucous membranes (Duke, 2002).
External Ids
Botanical Description
Evergreen shrub or small tree with glossy, dark green, leathery, finely toothed leaves. Small, fragrant, white flowers with a prominent central boss of yellow stamens are borne singly or in small clusters in the leaf axils. Commercial tea is made from the young leaves and unopened leaf buds ('sprouts'), processed differently to yield green, black, white or oolong tea from the same species.[15]
Evergreen tree (Myrtaceae), 8-12 m tall (occasionally to 20 m), with a pyramidal crown. Leaves are glossy, elliptical and aromatic. Small crimson flowers are borne in terminal clusters; the unopened flower buds, picked before they open and dried, are the 'cloves' of commerce and the medicinal/culinary part used.[2]
Habitat
Native to the subtropical and tropical forests and hillsides of East and South Asia (China, India, Myanmar); cultivated extensively across Asia, Africa and elsewhere on well-drained, acidic upland soils.[15]
Native to the Maluku Islands (Moluccas, the historic 'Spice Islands') of Indonesia, now cultivated throughout the tropics, notably Zanzibar, Madagascar, Sri Lanka and Indonesia, in warm, humid, well-drained tropical conditions.[2]
Harvesting
The youngest leaves and unopened leaf buds ('flush') are hand- or machine-picked repeatedly through the growing season; how the fresh leaf is subsequently processed (withered, rolled, oxidised, fixed and dried) determines whether it becomes green, black, white or oolong tea.[15]
Unopened flower buds are hand-picked while still green-pink, just before they would open, then sun-dried until they turn dark reddish-brown - the familiar clove spice.[2]
Traditional Uses
Clove has an ancient trade history and a long traditional use across Asian, African and European medicine as a dental analgesic (chewed or applied as oil for toothache), a digestive carminative, and an antiseptic. Modern research on its principal constituent eugenol supports strong analgesic, antimicrobial, antioxidant and anti-inflammatory activity, with clove oil remaining a recognised topical dental-pain remedy.[2]
Preparations
Young leaf, minimally oxidised, infused in hot water; the least-processed and most-studied form for antioxidant polyphenol content.
Concentrated leaf extract standardised to catechin (e.g. EGCG) content, taken as capsules; used in some clinical studies, though high-dose extracts carry rare hepatotoxicity concerns.
Dosage
The EU herbal monograph on green tea leaf (Camelliae sinensis non fermentatum folium) gives, for adults and elderly, 1.8-2.2 g of the whole or comminuted leaf in 100-150 mL of boiling water as an infusion, 3-5 times daily; a powdered herbal substance at 390 mg three times daily (up to 5 if necessary) is also listed. Contraindicated in gastric and duodenal ulcers, cardiovascular disorders such as hypertension and arrhythmia, and hyperthyroidism. Not recommended under 18 years. Educational reference only, not a prescription.
References
Drug Class Interactions
Not documented
Lookalikes Review
References & Sources
- Mancini, E., Beglinger, C., Drewe, J., Zanchi, D. et al (2017) 'Green tea effects on cognition, mood and human brain function: A systematic review', Phytomedicine, 34, pp. 26-37. doi:10.1016/j.phymed.2017.07.008 Meta-analysis / review
https://doi.org/10.1016/j.phymed.2017.07.008 - Musial, C., Kuban-Jankowska, A. and Gorska-Ponikowska, M (2020) 'Beneficial Properties of Green Tea Catechins', International Journal of Molecular Sciences, 21(5), pp. 1744. doi:10.3390/ijms21051744 Traditional / reference
https://doi.org/10.3390/ijms21051744 - Ohishi, T., Goto, S., Monira, P., Isemura, M. and Nakamura, Y (2016) 'Anti-inflammatory Action of Green Tea', Anti-inflammatory & Anti-allergy Agents in Medicinal Chemistry, 15(2), pp. 74-90. doi:10.2174/1871523015666160915154443 Traditional / reference
https://doi.org/10.2174/1871523015666160915154443 - Zhao, T., Li, C., Wang, S. and Song, X (2022) 'Green Tea (Camellia sinensis): A Review of Its Phytochemistry, Pharmacology, and Toxicology', Molecules, 27(12), pp. 3909. doi:10.3390/molecules27123909 Meta-analysis / review
https://doi.org/10.3390/molecules27123909 - Filippini, T., Malavolti, M., Borrelli, F., Izzo, A.A., Fairweather-Tait, S.J., Horneber, M. and Vinceti, M (2020) 'Green tea (Camellia sinensis) for the prevention of cancer', Cochrane Database of Systematic Reviews, 3(3), pp. CD005004. doi:10.1002/14651858.CD005004.pub3 Meta-analysis / review
https://doi.org/10.1002/14651858.CD005004.pub3 - Prasanth, M.I., Sivamaruthi, B.S., Chaiyasut, C. and Tencomnao, T (2019) 'A Review of the Role of Green Tea (Camellia sinensis) in Antiphotoaging, Stress Resistance, Neuroprotection, and Autophagy', Nutrients, 11(2), pp. 474. doi:10.3390/nu11020474 Meta-analysis / review
https://doi.org/10.3390/nu11020474 - Bedrood, Z., Rameshrad, M. and Hosseinzadeh, H (2018) 'Toxicological effects of Camellia sinensis (green tea): A review', Phytotherapy Research, 32(7), pp. 1163-1180. doi:10.1002/ptr.6063 Meta-analysis / review
https://doi.org/10.1002/ptr.6063 - Hamilton-Miller, J.M.T (2001) 'Anti-cariogenic properties of tea (Camellia sinensis)', Journal of Medical Microbiology, 50(4), pp. 299-302. doi:10.1099/0022-1317-50-4-299 Meta-analysis / review
https://doi.org/10.1099/0022-1317-50-4-299 - Conde, V.R., Alves, M.G., Oliveira, P.F. and Silva, B.M (2015) 'Tea (Camellia sinensis (L.)): a putative anticancer agent in bladder carcinoma?', Anti-Cancer Agents in Medicinal Chemistry, 15(1), pp. 26-36. doi:10.2174/1566524014666141203143143 Meta-analysis / review
https://doi.org/10.2174/1566524014666141203143143 - Moore, R.J., Jackson, K.G. and Minihane, A.M (2009) 'Green tea (Camellia sinensis) catechins and vascular function', British Journal of Nutrition, 102(12), pp. 1790-1802. doi:10.1017/S0007114509991218 Meta-analysis / review
https://doi.org/10.1017/S0007114509991218 - Gaur, R. and Bao, G.H (2021) 'Chemistry and Pharmacology of Natural Catechins from Camellia sinensis as Anti-MRSA Agents', Current Topics in Medicinal Chemistry, 21(17), pp. 1519-1537. doi:10.2174/1568026621666210524100632 Meta-analysis / review
https://doi.org/10.2174/1568026621666210524100632 - Tafazoli, A. and Tafazoli Moghadam, E (2020) 'Camellia Sinensis Mouthwashes in Oral Care: a Systematic Review', Journal of Dentistry (Shiraz), 21(4), pp. 249-262. doi:10.30476/DENTJODS.2020.83204.1045 Meta-analysis / review
https://doi.org/10.30476/DENTJODS.2020.83204.1045 - Albassam, A.A. and Markowitz, J.S (2017) 'An Appraisal of Drug-Drug Interactions with Green Tea (Camellia sinensis)', Planta Medica, 83(6), pp. 496-508. doi:10.1055/s-0043-100934 Meta-analysis / review
https://doi.org/10.1055/s-0043-100934 - Gramza-Michalowska, A (2014) 'Caffeine in tea Camellia sinensis - content, absorption, benefits and risks of consumption', Journal of Nutrition, Health & Aging, 18(2), pp. 143-149. doi:10.1007/s12603-013-0404-1 Meta-analysis / review
https://doi.org/10.1007/s12603-013-0404-1 - Chacko, S.M. et al (2010) 'Beneficial effects of green tea: a literature review'. Traditional / reference
https://scholar.google.com/scholar?q=Beneficial%20effects%20of%20green%20tea%3A%20a%20literature%20review - European Medicines Agency (HMPC) (2013) 'Community herbal monograph on Camellia sinensis (L.) Kuntze, non fermentatum folium'. Available at: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-camellia-sinensis-l-kuntze-non-fermentatum-folium_en.pdf Traditional / reference
https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-camellia-sinensis-l-kuntze-non-fermentatum-folium_en.pdf - Drake, V.J (2015) 'Tea catechins and cardiovascular disease risk', 74(1), pp. 39--46. Traditional / reference
https://scholar.google.com/scholar?q=Tea%20catechins%20and%20cardiovascular%20disease%20risk - Nobre, A.C., Rao, A. and Owen, G.N (2008) 'L-theanine, a natural constituent in tea, and its effect on mental state', pp. 167--168. Traditional / reference
https://scholar.google.com/scholar?q=L-theanine%2C%20a%20natural%20constituent%20in%20tea%2C%20and%20its%20effect%20on%20mental%20state - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Misaka, S., Yatabe, J., Muller, F., Takano, K., Kawabe, K., Glaeser, H., Yatabe, M.S., Onoue, S., Werba, J.P., Watanabe, H., Yamada, S., Fromm, M.F. and Kimura, J (2014) 'Green tea ingestion greatly reduces plasma concentrations of nadolol in healthy subjects', Clinical Pharmacology and Therapeutics, 95(4), pp. 432-438. doi:10.1038/clpt.2013.241 Randomized trial
https://doi.org/10.1038/clpt.2013.241 - Werba, J.P., Misaka, S., Giroli, M.G., Shimomura, K., Amato, M., Simonelli, N., Vigo, L. and Tremoli, E (2018) 'Update of green tea interactions with cardiovascular drugs and putative mechanisms', Journal of Food and Drug Analysis, 26(2S), pp. S72-S77. doi:10.1016/j.jfda.2018.01.008 Meta-analysis / review
https://doi.org/10.1016/j.jfda.2018.01.008
- Haro-Gonzalez, J.N., Castillo-Herrera, G.A., Martinez-Velazquez, M. and Espinosa-Andrews, H (2021) 'Clove Essential Oil (Syzygium aromaticum L. Myrtaceae): Extraction, Chemical Composition, Food Applications, and Essential Bioactivity for Human Health', Molecules, 26(21), pp. 6387. doi:10.3390/molecules26216387 Meta-analysis / review
https://doi.org/10.3390/molecules26216387 - Batiha, G.E., Alkazmi, L.M., Wasef, L.G., Beshbishy, A.M. and others (2020) 'Syzygium aromaticum L. (Myrtaceae): Traditional Uses, Bioactive Chemical Constituents, Pharmacological and Toxicological Activities', Biomolecules, 10(2), pp. 202. doi:10.3390/biom10020202 Meta-analysis / review
https://doi.org/10.3390/biom10020202 - Vicidomini, C., Roviello, V. and Roviello, G.N (2021) 'Molecular Basis of the Therapeutical Potential of Clove (Syzygium aromaticum L.) and Clues to Its Anti-COVID-19 Utility', Molecules, 26(7), pp. 1880. doi:10.3390/molecules26071880 Meta-analysis / review
https://doi.org/10.3390/molecules26071880 - Irahal, I.N., Guenaou, I., Lahlou, F.A., Hmimid, F. and others (2022) 'Syzygium aromaticum bud (clove) essential oil is a novel and safe aldose reductase inhibitor: in silico, in vitro, and in vivo evidence', Hormones (Athens), 21(2), pp. 229-240. doi:10.1007/s42000-021-00347-6 Preclinical
https://doi.org/10.1007/s42000-021-00347-6 - Yassin, M.T., Mostafa, A.A. and Al-Askar, A.A (2020) 'In vitro anticandidal potency of Syzygium aromaticum (clove) extracts against vaginal candidiasis', BMC Complementary Medicine and Therapies, 20(1), pp. 25. doi:10.1186/s12906-020-2818-8 Preclinical
https://doi.org/10.1186/s12906-020-2818-8 - Kiki, M.J (2023) 'In Vitro Antiviral Potential, Antioxidant, and Chemical Composition of Clove (Syzygium aromaticum) Essential Oil', Molecules, 28(6), pp. 2421. doi:10.3390/molecules28062421 Preclinical
https://doi.org/10.3390/molecules28062421 - Radunz, M., da Trindade, M.L.M., Camargo, T.M., Radunz, A.L. and others (2019) 'Antimicrobial and antioxidant activity of unencapsulated and encapsulated clove (Syzygium aromaticum, L.) essential oil', Food Chemistry, 276, pp. 180-186. doi:10.1016/j.foodchem.2018.09.173 Preclinical
https://doi.org/10.1016/j.foodchem.2018.09.173 - Shakeel, F., Alam, P., Ali, A., Alqarni, M.H. and others (2021) 'Investigating Antiarthritic Potential of Nanostructured Clove Oil (Syzygium aromaticum) in FCA-Induced Arthritic Rats: Pharmaceutical Action and Delivery Strategies', Molecules, 26(23), pp. 7327. doi:10.3390/molecules26237327 Preclinical
https://doi.org/10.3390/molecules26237327 - Tu, Z., Moss-Pierce, T., Ford, P. and Jiang, T.A (2014) 'Syzygium aromaticum L. (Clove) extract regulates energy metabolism in myocytes', Journal of Medicinal Food, 17(9), pp. 1003-1010. doi:10.1089/jmf.2013.0175 Preclinical
https://doi.org/10.1089/jmf.2013.0175 - Banerjee, S., Panda, C.K. and Das, S (2006) 'Clove (Syzygium aromaticum L.), a potential chemopreventive agent for lung cancer', Carcinogenesis, 27(8), pp. 1645-1654. doi:10.1093/carcin/bgi372 Preclinical
https://doi.org/10.1093/carcin/bgi372 - Bhowmik, D., Kumar, K.P.S., Yadav, A., Srivastava, S., Paswan, S. and Dutta, A.S (2012) 'Recent trends in Indian traditional herbs Syzygium aromaticum and its health benefits', 1(1), pp. 13--23. Traditional / reference
https://scholar.google.com/scholar?q=Recent%20trends%20in%20Indian%20traditional%20herbs%20Syzygium%20aromaticum%20and%20its%20health%20benefits - Royal Botanic Gardens, Kew (n.d.). Available at: https://powo.science.kew.org Traditional / reference
https://powo.science.kew.org - World Health Organization (2002) 'WHO Monographs on Selected Medicinal Plants'. Traditional / reference
https://scholar.google.com/scholar?q=WHO%20Monographs%20on%20Selected%20Medicinal%20Plants - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.